Microsoft Corporation (MSFT) has seen some recent volatility in the market and its common shares closed trading at $178.84 yesterday. Investors are starting to take interest of MSFT as the common shares traded as high as $183.65 and as low as $179.90 in the prior trading session.
Microsoft Corporation (MSFT) average trading volume is 56.23M. However, in the prior trading session Microsoft Corporation (MSFT) exchanged 36,839,168 shares. The first support level on MSFT is $178.29 and the first upside resistance level on MSFT is $190.65. MSFT 50day moving average is $163.03 and MSFT two hundred day moving average is $159.91.
Microsoft Corporation (MSFT) current performance has been shown by the recent movement in MSFT common shares. MSFT has performed 17.51% over the past 30 days, MSFT has performed 0.36% over the past quarter and MSFT has shown 41.05% over the past year. Microsoft Corporation (MSFT) has a 52 week range of $119.01 to $190.70. Microsoft Corporation (MSFT) is trading 51.89% from its 52 week low and -5.21% from its 52 week high. Microsoft Corporation (MSFT) is showing a 0.71% short float showing the quantity short in the float.
MSFT has 7.79B shares outstanding and 7.50B shares in the float. Microsoft Corporation (MSFT) currently has a market cap of $1407.22B and income of $43.67B. The EPS next quarter for MSFT is 1.39 and projected EPS net year is 9.14%. The market cap of Microsoft Corporation (MSFT) at $1407.22B signifies how many Investors own shares of MSFT and is calculated off the last price ($178.84) of MSFT and the quantity of shares outstanding (7.79B) with Microsoft Corporation (MSFT).
Microsoft Corporation (MSFT) has aggregate cash (mrq) of 137.64B, aggregate cash per share (mrq) of 18.15, aggregate debt of MSFT rests at 84.02B and aggregate debt/equity (mrq) is 73.38. Microsoft Corporation (MSFT) operational cash flow (ttm) is 58.11B and MSFT leveraged free cash flow (ttm) is 36.2B.
MSFT is trading 5.03% above (bullish) its SMA20, 11.74% above (bullish) its SMA50 and 18.46% above (bullish) its SMA200.
In recent news, on May 5, 2020, it was announced, Adaptive Biotechnologies and Microsoft launch virtual ImmuneRACE study to inform novel COVID-19 diagnostics to address unmet needs in testing. In this news it stated, LabCorp, through its Covance drug development business, will provide a safe, in-person COVID-19 sample collection service from the convenience of patients’ homes De-identified data about immune response to COVID-19 will be made freely available to advance public health solutions
About Microsoft Corporation (MSFT):
Redmond, WA-based Microsoft Corporation is one of the largest broad-based technology providers in the world. The company dominates the PC software market with more than 80% of the market share for operating systems. The company’s Office 365 application suite is one of the most popular productivity software globally.